Last updated on March 2020

Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Intrauterine Growth Retardation
  • Age: Between 18 - 100 Years
  • Gender: Female

Inclusion Criteria:

  • Patient over 18 years being at a gestational age 22 and <34 weeks of gestation with vascular fetal growth retardation defined according CNGOF
  • Ultrasound Estimated fetal weight below the 10th percentile
  • Clinical and ultrasound findings suggesting pathologically impaired growth or diminished foetal well-being
  • Clinical and ultrasound findings suggesting placental insufficiency
  • Precise dating of pregnancy with an ultrasound between 11 + 0 and 13 + 6 weeks of gestation
  • Written informed consent

Exclusion Criteria:

  • multiple pregnancy or identified cause of IUGR (intra-uterine growth retardation)
  • Patient with an immediate indication of fetal extraction
  • Women with a history of venous thromboembolism or already treated with anti-coagulant
  • Women with a contraindication to enoxaparin treatment at prophylactic doses
  • Patient refusing to participate or unable to consent
  • Patient with less than 80,000 platelets / mm 3 with the initial assessment

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.